Objectives: There are several problems and complications related to the Total Parenteral Nutrition (TPN) services. The pharmacist plays a crucial role in preventing these problems. Therefore, in this study, we aimed to assess the economic outcomes of pharmacist intervention in cost avoidance related to TPN services at a public hospital in Riyadh city, Saudi Arabia. Methods: Cohort prospective analysis of data collected regarding pharmacist intervention in TPN services provided to neonates, pediatrics and adult patients was performed. TPN services were provided 8 hr in a day and 7 days in a week. The study site was a 300-bed public hospital at the Ministry of Health (MOH) in Riyadh city, Saudi Arabia. The pharmacist reviews and prepares TPN and he pharmacist documents any or all TPN-related problems before the preparation of TPN or after dispensing it. The pharmacist uses an International Study Model to measure level of activity and provides rational of clinical intervention, recommendation, patient outcome, impact of pharmacoeconomics and related cost analysis. Results: The pharmacist identified a total of 402 TPN-related problems. The total number of TPN services provided was 394 prescribed to 82 patients. Of these, 209 (51.99%) and 193 (48.01%) interventions were provided to males and females, respectively. The total cost avoidance from pharmacist intervention in 1 year was 578,926.89 USD. The highest cost avoidance of TPN interventions was recorded for potentially significant (54.90%; 100,040.91 USD) and potentially serious problems (33.33%; 244,696.83 USD). The maximum cost avoidance in the case of rational clinical activities was recorded for TPN consultations (325,695.76 USD) followed by incompatibility (275,802.66) and inappropriate route (189,912.34 USD). The maximum cost avoidance related to patient outcome was recorded for patient condition improved (489,830.93 USD) and laboratory value improved (89,095.96). The maximum pharmacoeconomic cost avoidance impact was the patient duration of hospital stay decreased (226; 332,220.70 USD) and reduction in the drug therapy monitoring (246,227.15 USD). Conclusion: The clinical pharmacist responsible for TPN services plays an essential role in preventing TPN-related problems and avoid the unnecessary economic burden on the healthcare system. Expanding the role TPN clinical pharmacist is highly recommended for all TPN services to reduce the economic burden on healthcare system in Saudi Arabia.
INTRODUCTION
The strategic plan on pharmacy was released in 2012 with several general goals and initiatives. 1 The new and updated version of this plan along with the current evaluation and inclusion of New Saudi Vision 2030 was released in 2018. 2 This version states several tools for monitoring the plan, implementation and outcomes of the pharmacy practice programs. 1 The cost avoidance or cost impact was one of the current application tools. 3 Several international publications have explored the impact of cost avoidance on the pharmacist performance in different clinical pharmacy programs including nutrition support pharmacy. [4] [5] [6] In addition, several local investigations used the tool and showed the high-cost impact of some pharmacy programs. [7] [8] [9] [10] However, to the best of our knowledge, there are no studies conducted on the nutrition support services and their economic impact and cost avoidance in the KSA, Gulf and Middle Eastern countries. Therefore, in this study, we aimed to explore the economic impact of pharmacist interventions with nutrition support services at a public hospital located in Riyadh city, KSA.
METHODS
This is a cohort prospective analysis of 12-month data of 2015 regarding pharmacist intervention by providing TPN services to neonates, pediatrics and adult patients. TPN services are provided at the public hospital belonging to the MOH; it provides services for 8 hr in a day and 7 days in a week and has 300 beds. The hospital has following specialties: adult's endocrinology, adult's nephrology pediatrics, adult's cardiology, adults internal medicine, adults surgery, adults critical care, NICU, PICU and obstetrics and gynecology. The hospital has ambulatory care services and emergency services with above specialties. In addition, the hospital had comprehensive pharmaceutical services including inpatient pharmacy and ambulatory care pharmacy. Furthermore, the TPN services, drug information services and computerized physician order entry system is available at both inpatient and outpatient units. In 2009s, the pharmacy services established TPN services starting from physician prescribing it to pharmacist reviewing, preparing and dispensing it; the nurse administers the preparation to the patients. After 5 years, the pharmacy improved the services by in-stalling the automated compounding system techniques. TPNrelated problems were documented before preparation and after dispensing the TPN order. The pharmacist intervention used an International Study Model, which measures the level of activity and provides rational of clinical intervention, recommendation, patient outcome impact of pharmacoeconomics and related cost analysis. 11, 12 The data were gathered and analyzed by using the Survey Monkey system.
RESULTS
The pharmacist identified a total of 402 TPN-related problems. A total of 394 TPN orders were prescribed to 82 patients. The rate of intervention was 4.9 per patient. Of those, 209 (51.99%) and 193 (48.01%) were provided to males and females, respectively. The majority of patients were Saudi (266 (66.2%)) patients (non-Saudi patients were 136 (33.8%) in number). The majority of patients were neonates (303 (75.56%)) followed by pediatrics (97 (24.19%)) ( 1). (Tables 5 and 6 ). The maximum rational cost avoidance in terms of clinical activities was recorded for TPN consultations expected because most of our patients were Saudi nationals. The majority of the cost avoidance were recorded for neonates and pediatrics as most of the TPN candidates were pediatric patients. Most of the cost avoidance was recorded by senior registrar physician because of most of them committed potential mistakes of total parenteral nutrition. The maximum cost avoidance was recorded for potentially severe or significant interventions because the complications would be dangerous and highly risky to the patient even with the low number of interventions. 13 The maximum cost implicated for TPN problems were general TPN consultations and TPN incompatibility; however, these problems lead to significant complications and great sequences of additional cost. Consequently, a great deal of cost is saved. The maximum cost avoidance was recorded for patient conditions improved. This might be related to the reduction of duration of hospital stay and drug therapy monitoring. That is be expected with serious or significant TPN related problems. The economic impact of TPN pharmacist was very substantial. The economic impact documentation of prevention intervention with TPN services is highly recommended at MOH hospitals in the KSA.
CONCLUSION
The economic outcomes of pharmacist intervention through TPN services is vital. In future, we should target to expand the TPN services managed by the pharmacist at all MOH healthcare institutions in the KSA.
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DISCUSSION
The pharmacoeconomic program was established during pharmacy strategic planning at MOH in the KSA. 1 Some pharmacoeconomic tools were used as the indicators to follow the implementation of pharmacy strategic plan and measure the economic outcomes of the pharmacy practice program. 3 In the main public hospital in Riyadh city, the pharmacy staff implemented those tools. The authors explored the economic impact of pharmacist intervention with TPN services. The findings showed high-cost avoidance due to prevention of TPN-related problems. However, it is less than the reported value in a previous study. 4 That might be because, the TPN services have been newly established, TPN pharmacist newly trained and newly started TPN services at the hospital. There is not of much a difference in the gender and related cost avoidance because most of the TPN-related problems were similar. The results showed two-third of the problems were related to Saudi patients, whereas one-third of them were related to non-Saudi patients. This is 
